News

15
Apr

Mast Cells: Can’t live with them, can’t live without them? – Webinar Q&A

Thank you for your interest in our webinar on the dual role of mast cells, titled "Mast Cells: Can't live with them, can't live without them?". Below, you will find the questions we did not have time to address during the live session with Dr. Marcus Maurer. Q: In cold activated urticaria, is some of it caused by clonotypic IgE which
Read more
18
Mar

Genoskin at the World Vaccine Congress in DC!

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingFrom April 1-4, 2024, the global vaccine community gathered for the World Vaccine Congress in Washington, D.C. Taking place at the heart of the nation's capital, the congress was a cornerstone event for vaccine professionals worldwide, offering a platform for sharing groundbreaking research, fostering collaborations, and exploring the latest
Read more
13
Mar

Naked Immunology – Webinar 7 – Mast Cells – Marcus Maurer

Top-level science through the eyes of an expert.The seventh Webinar. The seventh webinar in the Naked Immunology series is now scheduled on April 8, 2024 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Marcus Maurer, MD, Professor of Dermatology and Allergy, Co‐Director
Read more
29
Feb

The Silent Crisis in Biomedical Research: Beyond Macaques

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, has
Read more
29
Feb

Immunogenicity series: Wanted Immunogenicity for Vaccine Development

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: Global
Read more
15
Feb

Genoskin at SOT 63rd Annual Meeting and ToxExpo

Genoskin at SOT 63rd Annual Meeting and ToxExpoPioneering Human Skin Models for Advanced Toxicology ResearchAs the world of toxicology convened for the Society of Toxicology 63rd Annual Meeting and ToxExpo, Genoskin was excited to announce its participation in this event, which took place from March 10-14 at the Salt Palace Convention Center in Salt Lake City. This year, Genoskin showcased
Read more